Glaxo SmithKline Pharmaceuticals announced a marginal rise in standalone net profit for the quarter ended September 2016. During the quarter, the profit of the company rose 3.45% to Rs 988.50 million from Rs 955.50 million in the same quarter last year.
Revenues for the quarter rose 11.37% to Rs 7,991.00 million, compared with Rs 7,175 million for the prior year period.
Operating margin for the quarter stood at 17.61 percent as compared to 17.85 percent for the previous year period. Operating Income for the quarter was Rs 1,407.40 million, compared with Rs 1281 million in the previous year period.
Earnings per share for the quarter stood at Rs 11.70, registering 3.54% growth over previous year period.
| Quarterly Results - Standalone (Rs in mn) |
| As at | Sep - 16 | Sep - 15 | %Change |
| Revenues | 7,991.00 | 7,175.00 | 11.37 |
| Net Profit | 988.50 | 955.50 | 3.45 |
| Diluted EPS | 11.70 | 11.30 | 3.54 |
Shares of the company gained Rs 9.4, or 0.32%, to trade at Rs 2,929.60. The total volume of shares traded was 957 at the BSE (2.22 p.m., Thursday).
